Literature DB >> 5000552

Heterotopic ossification in the paraplegic patient.

L H Venier, J F Ditunno.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5000552

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


× No keyword cloud information.
  8 in total

1.  G. Heiner sell distingushed lecture: american spinal injury association (Asia) 40th anniversary: beginnings, accomplishments and future challenges.

Authors:  Kristjan T Ragnarsson
Journal:  Top Spinal Cord Inj Rehabil       Date:  2013

Review 2.  Care of spinal-cord-injured patients after the acute period.

Authors:  W Levinson; G Ward; M Valleroy
Journal:  J Gen Intern Med       Date:  1989 Jul-Aug       Impact factor: 5.128

3.  True heterotopic bone in the paralyzed patient.

Authors:  C E Blane; I Perkash
Journal:  Skeletal Radiol       Date:  1981       Impact factor: 2.199

4.  [Heterotopic ossification spinal cord injury. Management through early diagnosis and therapy].

Authors:  D Maier
Journal:  Orthopade       Date:  2005-02       Impact factor: 1.087

5.  Development of heterotopic ossifications, blood markers and outcome after radiation therapy in spinal cord injured patients.

Authors:  H Krauss; D Maier; V Bühren; F Högel
Journal:  Spinal Cord       Date:  2014-11-25       Impact factor: 2.772

6.  An unusual site of heterotopic calcification.

Authors:  J C Wong; M A Rossleigh; C L Christian; R L Philips
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668

7.  The use of spect/ct in the evaluation of heterotopic ossification in para/tetraplegics.

Authors:  Maurício Coelho Lima; Marcus Ceregati Passarelli; Virgílio Dario; Bruno Rodrigues Lebani; Paulo Henrique Silva Monteiro; Celso Darío Ramos
Journal:  Acta Ortop Bras       Date:  2014       Impact factor: 0.513

Review 8.  The hypoxic microenvironment: a driving force for heterotopic ossification progression.

Authors:  Yifei Huang; Xinyi Wang; Hui Lin
Journal:  Cell Commun Signal       Date:  2020-02-07       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.